Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study

Autor: Dorte Melgaard, Jeanette Sørensen, Johannes Riis, Tine S. Ovesen, Peter Leutscher, Suzette Sørensen, Julie K. Knudsen, Caspar Bundgaard-Nielsen, Jeanette Ejstrup, Ann-Maria Jensen, Mette Borre, Anne L. Krarup

Publikováno v: Nutrients; Volume 14; Issue 6; Pages: 1296
Melgaard, D, Sørensen, J, Riis, J, Ovesen, T S, Leutscher, P, Sørensen, S, Knudsen, J K, Bundgaard-Nielsen, C, Ejstrup, J, Jensen, A-M, Borre, M & Krarup, A L 2022, ' Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome : A Feasibility Study ', Nutrients, vol. 14, no. 6, 1296 . https://doi.org/10.3390/nu14061296
Melgaard, D, Sørensen, J, Riis, J, Ovesen, T S, Leutscher, P, Sørensen, S, Knudsen, J K, Bundgaard-nielsen, C, Ejstrup, J, Jensen, A M, Borre, M & Krarup, A L 2022, ' Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome : A Feasibility Study ', Nutrients, vol. 14, no. 6, 1296 . https://doi.org/10.3390/nu14061296

BACKGROUND: Patients with inflammatory bowel disease (IBD) and symptoms of irritable bowel syndrome (IBS) may be intolerant to fermentable carbohydrates (FODMAPs). The aim of this study was to test the feasibility of eliminating and subsequently rein

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba89bcf51f1fa1a00d6ad2581c91128